Risedronate prevents bone disease and reduces tumour burden in a syngeneic model of multiple myeloma

被引：0
|
作者：
Lawson, MA
Coulton, L
Ebetino, FH
Gallagher, O
Prideaux, M
Vanderkerken, K
Croucher, PI
机构：
[1] Univ Sheffield, Sch Med, Div Clin Sci, Acad Unit Bone Biol, Sheffield S10 2TN, S Yorkshire, England
[2] Procter & Gamble Pharmaceut, New Drug Dev, Mason, OH USA
[3] Free Univ Brussels, Dept Hematol & Immunol, Brussels, Belgium
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2006年 / 21卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1160 / 1160
页数：1
相关论文
共 50 条
  • [1] Risedronate prevents bone disease and reduces tumour burden in a syngeneic model of multiple myeloma
    Lawson, M. A.
    Coulton, L.
    Ebetino, F. H.
    Gallagher, O.
    Prideaux, M.
    Vanderkerken, K.
    Croucher, P.
    CANCER TREATMENT REVIEWS, 2006, 32 : S35 - S35
  • [2] Risedronate prevents bone disease and reduces turnour burden in a syngeneic model of multiple myeloma.
    Lawson, M. A.
    Coulton, L.
    Ebetino, F. H.
    Gallagher, O.
    Prideaux, M.
    Vanderkerken, K.
    Croucher, P. I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S137 - S137
  • [3] Inhibition of p38α MAPK prevents the development of myeloma bone disease, reduces tumour burden and increases survival in murine models of myeloma
    Croucher, P. I.
    Coulton, L.
    Menu, E.
    Protter, A. A.
    Higgins, L. S.
    Medicherla, S.
    Vanderkerken, K.
    CANCER TREATMENT REVIEWS, 2006, 32 : S25 - S25
  • [4] ARQ-197, A SMALL-MOLECULE INHIBITOR OF C-MET, REDUCES TUMOUR BURDEN AND PREVENTS TUMOUR-ASSOCIATED BONE DISEASE IN A MURINE MODEL OF MYELOMA
    Chantry, A.
    Holly, E.
    Fisher, M.
    Jenny, D.
    Michelle, L.
    Darren, L.
    HAEMATOLOGICA, 2017, 102 : 500 - 500
  • [5] Anti-Sclerostin Treatment Prevents Multiple Myeloma Induced Bone Loss and Reduces Tumor Burden
    Reagan, Michaela R.
    McDonald, Michelle
    Terry, Rachael
    Pettitt, Jessica
    Le, Lawrence
    Mohanty, Sindhu
    Kneissel, Michaela
    Kramer, Ina
    Brooks, Daniel
    Bouxsein, Mary
    Rosen, Clifford J.
    Ghobrial, Irene M.
    Croucher, Peter
    BLOOD, 2015, 126 (23)
  • [6] High LDL Promotes Increased Tumour Burden, Bone Disease and Bortezomib Resistance in Multiple Myeloma
    Gamez, Beatriz
    Morris, Emma
    Rao, Srinivasa Rao
    Olechnowicz, Sam
    Park, Young Eun
    Sowman, Aneka
    Turner, Christina
    Kaya, Zeynep
    Edwards, James R.
    Edwards, Claire M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 15 - 15
  • [7] Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease
    Dallas, SL
    Garrett, IR
    Oyajobi, BO
    Dallas, MR
    Boyce, BF
    Bauss, F
    Radl, J
    Mundy, GR
    BLOOD, 1999, 93 (05) : 1697 - 1706
  • [8] ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo
    Lath, Darren L.
    Buckle, Clive H.
    Evans, Holly R.
    Fisher, Matthew
    Down, Jenny M.
    Lawson, Michelle A.
    Chantry, Andrew D.
    PLOS ONE, 2018, 13 (06):
  • [9] Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth
    Faict, Sylvia T.
    De Veirman, Kim
    Maes, Ken
    De Bruyne, Elke
    Heusschen, Roy
    Caers, Jo
    Vanderkerken, Karin
    Schots, Rik
    Menu, Eline
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
    Bradey, Alanah L.
    Fitter, Stephen
    Duggan, Jvaughn
    Wilczek, Vicki
    Williams, Connor M. D.
    Cheney, Emma AJ.
    Noll, Jacqueline E.
    Tangseefa, Pawanrat
    Panagopoulos, Vasilios
    Zannettino, Andrew C. W.
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345